Published in N Engl J Med on August 31, 1978
Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36
Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer (2009) 3.99
Systemic treatment of colorectal cancer. Gastroenterology (2008) 2.62
The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers. Ann Surg (1980) 1.45
CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg (1982) 1.38
The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials. Ann Surg (1984) 1.22
Predictive and prognostic molecular markers for cancer medicine. Ther Adv Med Oncol (2010) 1.18
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer. Br J Cancer (2011) 1.16
Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer (2009) 1.14
Prognostic value of CA 19.9 levels in colorectal cancer. Ann Surg (1992) 1.13
A prospective analysis of laboratory tests and imaging studies to detect hepatic lesions. Ann Surg (1982) 1.04
Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling? Clin Colorectal Cancer (2011) 1.04
Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator. Br Med J (1979) 1.00
Screening for colorectal cancer: established and emerging modalities. Nat Rev Gastroenterol Hepatol (2011) 0.99
Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer (1998) 0.99
Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy. Int J Colorectal Dis (2009) 0.98
Diagnostic significance of serum HMGB1 in colorectal carcinomas. PLoS One (2012) 0.97
Cutoff values of preoperative s-CEA levels for predicting survivals after curative resection of colorectal cancer. J Korean Med Sci (2005) 0.96
Prognostic value of preoperative serum tumor markers in gastric cancer. World J Clin Oncol (2014) 0.96
Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer. J Proteome Res (2009) 0.96
The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br J Cancer (1994) 0.95
Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Br J Cancer (1993) 0.95
An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. Mol Cell Proteomics (2011) 0.94
Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. Br J Cancer (1992) 0.94
Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker. Surg Today (1998) 0.93
Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer. Br J Cancer (1983) 0.92
Plasma protein profiles and prognosis in gastric cancer. Br J Cancer (1982) 0.92
Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer. Colorectal Dis (2008) 0.92
Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma. Br J Cancer (1981) 0.92
Measuring quality of care in the treatment of colorectal cancer: the moffitt quality practice initiative. J Oncol Pract (2007) 0.91
Carcinoembryonic antigen: enhancement of liver colonisation through retention of human colorectal carcinoma cells. Br J Cancer (1993) 0.90
Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response. World J Surg (2009) 0.90
Prognostic value of preoperative serum CEA level compared to clinical staging: II. Stomach cancer. Br J Cancer (1982) 0.90
Common genetic variants in Wnt signaling pathway genes as potential prognostic biomarkers for colorectal cancer. PLoS One (2013) 0.86
The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution. Am J Pathol (1989) 0.85
Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes. PLoS One (2011) 0.84
Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. Br J Cancer (2012) 0.83
The value of postoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the early detection of gastric cancer recurrence after curative resection. J Gastric Cancer (2014) 0.83
Carcinoembryonic antigen level of draining venous blood as a predictor of recurrence in colorectal cancer patient. J Korean Surg Soc (2011) 0.83
A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis? Br J Cancer (1988) 0.83
Prognostic factors in node-negative colorectal cancer: a retrospective study from a prospective database. Int J Colorectal Dis (2010) 0.81
Genetic polymorphisms of matrix metalloproteinases and clinical outcomes in colorectal cancer patients. Int J Med Sci (2013) 0.81
Impact of interleukin-10 gene polymorphisms on survival in patients with colorectal cancer. J Korean Med Sci (2013) 0.81
New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer. Br J Cancer (2007) 0.81
Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable. Int Surg (2015) 0.79
Selective capture of glycoproteins using lectin-modified nanoporous gold monolith. J Chromatogr A (2015) 0.78
Prioritization of cancer marker candidates based on the immunohistochemistry staining images deposited in the human protein atlas. PLoS One (2013) 0.78
Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period. Int J Colorectal Dis (2012) 0.78
Carcinoembryonic antigen and carbohydrate antigen 19-9 are prognostic predictors of colorectal cancer with unresectable liver metastasis. Oncol Lett (2012) 0.78
Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen. J Cancer Res Clin Oncol (2013) 0.77
Value of carcinoembryonic antigen assay in predicting hepatic metastases, local recurrence, and survival after curative resection of colorectal cancer. Surg Today (2006) 0.77
Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level: A Useful Tool for Prediction of Distant Metastasis in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision. Medicine (Baltimore) (2015) 0.76
Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemoradiotherapy. Medicine (Baltimore) (2016) 0.75
Treatment of local recurrence after primary restorative resection or Hartmann's operation for carcinoma of the colon and the rectum. Int J Colorectal Dis (1986) 0.75
D-Dimer and Carcinoembryonic Antigen Levels: Useful Indicators for Predicting the Tumor Stage and Postoperative Survival. Gastroenterol Res Pract (2016) 0.75
Comparison between surgical outcomes of colorectal cancer in younger and elderly patients. World J Gastroenterol (2011) 0.75
Potential Prognostic Impact of Baseline CEA Level and Surgery of Primary Tumor Among Patients with Synchronous Stage IV Colorectal Cancer: A Large Population Based Study. Indian J Surg Oncol (2015) 0.75
Comparative analysis of colorectal carcinoma staging using operative, histopathology and computed tomography findings. Int J Appl Basic Med Res (2017) 0.75
Simultaneous Detection of α-Fetoprotein and Carcinoembryonic Antigen Based on Si Nanowire Field-Effect Transistors. Sensors (Basel) (2015) 0.75
The prognostic significance and treatment modality for elevated pre- and postoperative serum CEA in colorectal cancer patients. Ann Surg Treat Res (2016) 0.75
Incorporation of serum carcinoembryonic antigen levels into the prognostic grouping system of colon cancer. Int J Colorectal Dis (2017) 0.75
Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells. J Exp Med (1975) 7.20
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A (1976) 6.82
Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med (1976) 5.05
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1980) 4.66
Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse. Nature (1975) 4.34
Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera. Proc Natl Acad Sci U S A (1979) 4.14
Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci U S A (1978) 3.99
Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1966) 3.56
Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 3.54
Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med (1979) 3.43
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics. J Exp Med (1977) 3.42
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer (1993) 2.89
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med (1982) 2.74
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures. Proc Natl Acad Sci U S A (1984) 2.54
Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens. J Exp Med (1981) 2.53
Partial purification of a serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1976) 2.42
Pathological review of breast lesions analyzed for estrogen receptor protein. Cancer Res (1975) 2.24
Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst (1977) 2.15
Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci U S A (1985) 2.14
Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins. Proc Natl Acad Sci U S A (1981) 2.09
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum (1994) 2.04
Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc Natl Acad Sci U S A (1988) 1.97
Ly phenotype of cytotoxic T cells for syngeneic tumor. J Exp Med (1976) 1.94
Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex. AIDS (1998) 1.89
Inhibition of leukemias in man by L-asparaginase. Cancer Res (1967) 1.88
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
Serological survey of normal humans for natural antibody to cell surface antigens of melanoma. Proc Natl Acad Sci U S A (1980) 1.86
Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J Exp Med (1982) 1.85
Suspension culture of a pigment-producing cell line derived from a human malignant melanoma. J Natl Cancer Inst (1968) 1.84
Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon. J Exp Med (1984) 1.81
Proceedings: Treatment of minimal breast cancer. Cancer (1974) 1.78
Anorectal melanoma. Cancer (1981) 1.77
Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg (1996) 1.77
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol (2000) 1.72
Generation of human monoclonal antibodies reactive with cellular antigens. Proc Natl Acad Sci U S A (1983) 1.71
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J Clin Oncol (1995) 1.71
Phase I trial of recombinant interferon gamma in cancer patients. J Clin Oncol (1986) 1.68
Serologic approaches to the study of cancer in animals and in man. Cancer Res (1968) 1.65
Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science (1966) 1.65
Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med (1992) 1.63
Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest (1988) 1.59
Induction and immunological properties of tumor necrosis factor. J Reticuloendothel Soc (1978) 1.53
Sacrococcygeal teratoma: the experience of four decades. J Pediatr Surg (1992) 1.53
Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52
Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop. Cancer Res (1975) 1.51
Quantifying the lag time to detect barriers in landscape genetics. Mol Ecol (2010) 1.51
Accuracy of fecal occult blood test interpretation. National Polyp Study Work Group. Ann Intern Med (1991) 1.50
Ly antigens: markers of T cell function on mouse spleen cells. J Immunol (1975) 1.49
Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg (1978) 1.49
Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma. J Exp Med (1983) 1.48
Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody. J Exp Med (1984) 1.48
Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol (2001) 1.48
Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg (1978) 1.46
The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg (1987) 1.44
Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum (1978) 1.44
Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck (1998) 1.44
Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology. Cancer (1981) 1.43
Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav (2005) 1.43
On the number and nature of antigen-sensitive lymphocytes in the blood of delayed-hypersensitive human donors. J Exp Med (1971) 1.42
Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera. Proc Natl Acad Sci U S A (1980) 1.41
T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg (1975) 1.40
Postoperative analgesia following thoracotomy in children: interpleural catheters. J Pediatr Surg (1993) 1.39
Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas. Cancer Res (1987) 1.38
Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets. Cancer Res (1986) 1.36
Toxicity of E. coli L-asparaginase in man. Cancer (1970) 1.36
Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test. J Natl Cancer Inst (1975) 1.36
Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res (1986) 1.36
Delayed hypersensitivity and transplantation immunity elicited by soluble antigens of chemically induced tumours in inbred guinea-pigs. Nature (1968) 1.32
GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines. Cancer Res (1994) 1.32
In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867). Antimicrob Agents Chemother (1984) 1.31
Immunogenic properties of reticulum cell sarcomas of SJL/J mice. J Natl Cancer Inst (1970) 1.30
Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. Proc Natl Acad Sci U S A (1987) 1.30
Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide. Proc Natl Acad Sci U S A (1985) 1.29
Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor. Cancer (1981) 1.28
Production of antibody to sheep red blood cells by human tonsil cells in vitro. Nature (1973) 1.28
Diagnosis and management of giant intrasacral schwannoma. Cancer (1992) 1.28
Macrophage factor controlling differentiation of B cells. J Immunol (1979) 1.28
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27
Somatic cell genetic analysis of human cell surface antigens: chromosomal assignments and regulation of expression in rodent-human hybrid cells. Proc Natl Acad Sci U S A (1984) 1.27
Screening for anxiety and depression in women with breast cancer. Psychiatry and medical oncology gear up for managed care. Psychosomatics (1999) 1.26
Minimal increase in use of breast-conserving surgery from 1986 to 1990. Med Care (1996) 1.26
Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med (1983) 1.26
A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients. J Affect Disord (1984) 1.25
Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. Cancer Res (1985) 1.24
Role of trace elements in cancer. Cancer Res (1975) 1.24
Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg (1995) 1.24
High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants. Cancer Res (1985) 1.24
Adolescent striae. Cutis (2000) 1.24
The effect of legislative requirements on the use of breast-conserving surgery. N Engl J Med (1996) 1.24
Stimulation of human tonsillar lymphocytes in vitro. Clin Exp Immunol (1966) 1.23
Toxicity of intravesical BCG and its management in patients with superficial bladder tumors. Cancer (1987) 1.23
Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg (1985) 1.22
Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22